Still it doesn't make sense. Testing other epitopes could have taken very little extra time. In case of mRNA vaccines, just run some trials in parallel. And surely, it's better to hedge your bets. Otherwise, we might…
What you are saying is simply not true. mRNA vaccines took absolutely no time to design, as they have an automated platform to synthesize any given mRNA. Companies have even disclosed they went from sequence to vaccine…
An ideal vaccine design should include different viral peptides, instead of just the whole spike protein. And one should also remove epitopes that mimic human proteins, both to increase efficiency and avoid rare…
Still it doesn't make sense. Testing other epitopes could have taken very little extra time. In case of mRNA vaccines, just run some trials in parallel. And surely, it's better to hedge your bets. Otherwise, we might…
What you are saying is simply not true. mRNA vaccines took absolutely no time to design, as they have an automated platform to synthesize any given mRNA. Companies have even disclosed they went from sequence to vaccine…
An ideal vaccine design should include different viral peptides, instead of just the whole spike protein. And one should also remove epitopes that mimic human proteins, both to increase efficiency and avoid rare…